Skip to content

SANUWAVE Health, Inc.: 10-Q filed 2018-11-19

What SANUWAVE Health, Inc. reported in its quarterly report filed 2018-11-19 (fiscal Q3 2018): 37 published measures, 99 facts as tagged in accession 0001654954-18-012966.

This filing

Form
10-Q (quarterly report)
Filed
2018-11-19
Fiscal period
fiscal Q3 2018
Accession
0001654954-18-012966 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANUWAVE Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-09-30723,604USD
At 2017-12-311,278,810USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-09-3014,191,386USD
At 2017-12-3111,159,637USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-09-30-13,467,782USD
At 2017-12-31-9,880,827USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-09-3072,311USD
At 2017-12-31730,184USD
At 2017-09-3040,226USD
At 2016-12-31133,571USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-825,142USD92
2018-01-01 to 2018-09-30-9,570,056USD273
2017-01-01 to 2017-12-31-5,537,936USD365
2017-07-01 to 2017-09-30-851,325USD92
2017-01-01 to 2017-09-30-2,760,794USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-2,271,566USD273
2017-01-01 to 2017-09-30-944,831USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-01-01 to 2018-09-3032,171USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-07-01 to 2018-09-30595,789USD92
2018-01-01 to 2018-09-301,393,271USD273
2017-07-01 to 2017-09-30161,585USD92
2017-01-01 to 2017-09-30422,199USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-01-01 to 2018-09-301,663,063USD273
2017-01-01 to 2017-09-30844,683USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-32,171USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-09-30-114,541,440USD
At 2017-12-31-104,971,384USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-09-3072,637USD
At 2017-12-3160,369USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-09-302,474,496USD273
2017-01-01 to 2017-09-30482,295USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-2,670,356USD92
2018-01-01 to 2018-09-30-5,913,363USD273
2017-07-01 to 2017-09-30-647,778USD92
2017-01-01 to 2017-09-30-2,577,842USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-09-30634,470USD
At 2017-12-311,204,524USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-07-01 to 2018-09-30395,604USD92
2018-01-01 to 2018-09-304,070,326USD273
2017-07-01 to 2017-09-30160,978USD92
2017-01-01 to 2017-09-30496,997USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-09-3014,165,427USD
At 2017-12-3111,159,637USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-09-301,560,965USD
At 2017-12-311,496,523USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-09-30152,706USD
At 2017-12-31152,520USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-07-01 to 2018-09-303,082,551USD92
2018-01-01 to 2018-09-306,790,931USD273
2017-07-01 to 2017-09-30747,679USD92
2017-01-01 to 2017-09-302,858,518USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2018-09-30240,973USD
At 2017-12-31231,532USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2018-07-01 to 2018-09-30412,195USD92
2018-01-01 to 2018-09-30877,568USD273
2017-07-01 to 2017-09-3099,901USD92
2017-01-01 to 2017-09-30280,676USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2018-07-01 to 2018-09-30183,594USD92
2018-01-01 to 2018-09-30515,703USD273
2017-07-01 to 2017-09-3061,684USD92
2017-01-01 to 2017-09-30141,523USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-07-01 to 2018-09-30661,736USD92
2018-01-01 to 2018-09-301,379,517USD273
2017-07-01 to 2017-09-30266,837USD92
2017-01-01 to 2017-09-30965,084USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-09-30155,107,127shares
At 2017-12-31139,300,122shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-09-30100,979,533USD
At 2017-12-3194,995,040USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2018-09-30-60,982USD
At 2017-12-31-43,783USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2018-09-3016,497USD
At 2017-12-3113,917USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-09-30746,083USD
At 2017-12-31673,600USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2018-07-01 to 2018-09-30-831,372USD92
2018-01-01 to 2018-09-30-9,587,255USD273
2017-07-01 to 2017-09-30-830,755USD92
2017-01-01 to 2017-09-30-2,753,991USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-07-01 to 2018-09-302,415,106USD92
2018-01-01 to 2018-09-305,391,511USD273
2017-07-01 to 2017-09-30475,377USD92
2017-01-01 to 2017-09-301,875,891USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-07-01 to 2018-09-305,709USD92
2018-01-01 to 2018-09-3016,733USD273
2017-07-01 to 2017-09-305,465USD92
2017-01-01 to 2017-09-3017,543USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-07-01 to 2018-09-301,845,214USD92
2018-01-01 to 2018-09-30-3,656,693USD273
2017-07-01 to 2017-09-30-203,547USD92
2017-01-01 to 2017-09-30-182,952USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-09-30151,227USD273
2017-01-01 to 2017-09-300USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-30-49,661USD273
2017-01-01 to 2017-09-30-200,850USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-309,441USD273
2017-01-01 to 2017-09-30-55,844USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2018-01-01 to 2018-09-30184,442USD273
2017-01-01 to 2017-09-30722,467USD273

Inspect the source

Entity
SANUWAVE Health, Inc. / CIK 0001417663
Captured
2026-09-20T08:02:35.518Z
SEC response SHA-256
51a2d5afc6b3c84f5ebe71aa20944ba7646a9b22810a9cc023a45d564e5104f2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001417663.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))